Suchergebnisse - "Raal, Frederick"

PubPharm (35)

1

Estimating potential cardiovascular health benefits of improved population level control of LDL cholesterol through a twice-yearly siRNA-based approach : A simulation study of a health-system level intervention

enthalten in: Atherosclerosis | 2024

von Ray, K. | Gunn, L. | Conde, L. | +8

2

Evolocumab in paediatric heterozygous familial hypercholesterolaemia : cognitive function during 80 weeks of open-label extension treatment

enthalten in: European journal of preventive cardiology | 2024

von Santos, R. | Ruzza, A. | Wang, B. | +12

3

Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia : Results From the ORION-5 Randomized Clinical Trial

enthalten in: Circulation | 2024

von Raal, F. | Durst, R. | Bi, R. | +5

CommentIn: Circulation. 2024 Jan 30;149(5):363-366. - PMID 38285739

4

Inclisiran in patients with prior myocardial infarction : A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials

enthalten in: Atherosclerosis | 2023

von Landmesser, U. | Koenig, W. | Leiter, L. | +6

5

Effect of inclisiran on lipids in primary prevention : the ORION-11 trial

enthalten in: European heart journal | 2022

von Ray, K. | Kallend, D. | Leiter, L. | +8

CommentIn: Eur Heart J. 2022 Dec 21;43(48):5058-5060. - PMID 36331327

6

Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE) : a single-arm, multicentre, open-label extension of HAUSER-RCT

enthalten in: The lancet. Diabetes & endocrinology | 2022

von Santos, R. | Ruzza, A. | Hovingh, G. | +14

CommentIn: Lancet Diabetes Endocrinol. 2022 Oct;10(10):686-688. - PMID 36075245

7

Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia

enthalten in: Journal of clinical lipidology | 2022

von Gaudet, D. | Ruzza, A. | Bridges, I. | +12

8

Evinacumab for Homozygous Familial Hypercholesterolemia

enthalten in: The New England journal of medicine | 2020

von Raal, F. | Rosenson, R. | Reeskamp, L. | +114

CommentIn: N Engl J Med. 2020 Aug 20;383(8):775-776. - PMID 32813955

9

Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol

enthalten in: The New England journal of medicine | 2020

von Ray, K. | Wright, R. | Kallend, D. | +109

CommentIn: Nat Rev Cardiol. 2020 Jun;17(6):321. - PMID 32235900

10

Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia

enthalten in: The New England journal of medicine | 2020

von Raal, F. | Kallend, D. | Ray, K. | +70